Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ500,5501,50,36
KB783784-1,20
PKN73,0273,160,58
Msft-3,16
Nokia3,7963,80,13
IBM-0,91
Daimler AG42,4842,495-2,63
PFE-0,36
22.02.2020 2:00:00
Indexy online
AD Index online
select
AD Index online
 

  • 21.02.2020
DaVita (DVA, NY Consolidated)
Závěr k 21.2.2020 Změna (%) Změna (USD) Objem obchodů (ks)
84,09 -0,66 -0,56 755 418
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 22.02.2020
Popis společnosti
Obecné informace
Název společnostiDavita Inc
TickerDVA
Kmenové akcie:Ordinary Shares
RICDVA
ISINUS23918K1088
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky31.12.2019
Počet zaměstnanců k 31.12.2018 77 700
Akcie v oběhu k 31.12.2019 125 842 853
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice2000 16th St
MěstoDENVER
PSČ80202-5158
ZeměUnited States
Kontatní osobaJim Gustafson
Funkce kontaktní osobyVice President - Investor Relations
Telefon13 105 362 668
Fax13026365454
Kontatní telefon13 105 362 585

Business Summary: DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2019, Davita Inc revenues decreased less than 1% to $11.39B. Net income before extraordinary items increased 14% to $705.5M. Revenues reflect Revenue Sales of Goods & Services increase of 2% to $10.92B, Provision for uncollectible accounts decrease of 56% to $21.7M, also reflect Other revenues decrease of 34% to $491.8M.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Healthcare Facilities & Services - NEC
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSKidney Dialysis Centers
NAICSAll Other Outpatient Care Centers
NAICSMedical Laboratories
NAICSResearch and Development in the Physical, Engineering, and Life Sciences
NAICSAll Other Miscellaneous Ambulatory Health Care Services
SICKidney Dialysis Centers
SICSpecialty Outpatient Clinics, Nec
SICMedical Laboratories
SICCommercial Physical Research
SICHealth And Allied Services, Nec



  • Poslední aktualizace: 22.02.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardKent Thiry6301.06.2019
Chief Executive Officer, DirectorJavier Rodriguez4801.06.2019
Chief Financial Officer, TreasurerJoel Ackerman5327.02.2017
Chief Accounting Officer, Group Vice PresidentJohn Winstel4828.10.201928.10.2019
Chief Compliance OfficerJames Hearty50
Group Vice President - purchasing and government affairsLeAnne Zumwalt6001.01.2008
Chief Legal OfficerKathleen Waters51